Please contact Madeline Bacon with any questions.
Mail: The Rubin Institute for Advanced Orthopedics
Sinai Hospital of Baltimore
2401 West Belvedere Avenue
Baltimore, Maryland 21215, USA
|You can register online or by printing out the registration form and sending the
completed form to the fax number or to the mailing address that is listed on the
form. If you are not using your own credit card to pay the registration fee or
you are using your credit card to pay for multiple registration fees,
please complete this form.
Click here to view a PDF of the course brochure.
The course venue is the Four Seasons Hotel (200 International Drive) in the
heart of Baltimore’s Inner Harbor. The discounted per-room fee for course
attendees is $199 per night (plus tax). It is highly recommended that you make
your reservations early. The special room rate for course participants is
offered only on a space-available basis through July 30, 2013.
To make a reservation, visit the hotel web site, select the dates of your reservation, click on "Corporate/Promo Code," and then enter code "SI0821". You can also call 1.800.819.5053 and mention “Sinai Joint Course.”
2013 Course Schedule
The Seventh Annual Hip and Knee Course: Modern Techniques in Hip and Knee Reconstruction and Preservation
Date: August 23–24, 2013
Location: Four Seasons Hotel, Baltimore, Maryland
Course Directors: Michael A. Mont, MD, Thomas P. Schmalzried, MD, Ronald E. Delanois, MD, Harpal S. Khanuja, MD, and James Nace, DO
This conference will bring together the world leaders in hip and knee joint preservation and reconstruction. The course format will consist of fast paced, lively discussions, didactic presentations, and surgical demonstrations. The goal is to identify, outline, and discuss the current state of knowledge in the clinical and basic sciences as they pertain to the diagnosis and treatment of hip and knee disorders in adult patients. LifeBridge Health designates this live educational activity for a maximum of 12.0 AMA PRA Category 1 CreditsTM.
Topics discussed will include new surgical approaches, techniques, prostheses, and computer-assisted surgery/robotics. General topics will include infection, deep vein thrombosis, pain management, rehabilitation, and biologicals. The latest technology and the economics of total knee and hip arthroplasty will be addressed.The new surgical approaches to the hip that will be taught will include the various ways to perform an anterior approach. Pathomechanics, patient selection, and treatment options for femoroacetabular impingement will be discussed. A comprehensive range of standard and resurfacing hip arthroplasty options will be presented, with a focus on the current principles of patient selection, implant selection, and surgical techniques, as well as avoiding complications. Comparisons will be made between current generation metal- on-polyethylene and alternate bearing surfaces. Pertinent basic science issues will be presented and discussed, which will include tribology, retrieval analyses, pathology, wear debris exposure, and related concerns. Future directions, such as dual mobility hip designs, short stems for total hip arthroplasty, and the evolution of bearing surfaces will also be addressed.
Joint preserving topics will be discussed such as new biologics and knee re-alignment—both traditional and newer schemes. Biological cell regulation therapy, shape matching, cross-linked polyethylenes, and minimally invasive surgery will be tackled. Presentations will include new implant choices for total knee arthroplasty utilizing innovative and less invasive technologies such as robotics and navigation.
- Identify new and currently available technology to treat adult hip and knee disorders
- Discuss the current state of knowledge in joint preservation and reconstruction
- Understand current and emerging surgical and nonsurgical approaches for the treatment of arthritis in the hip and in the knee
- Evaluate therapies and new approaches for relieving pain and improving function
- See the future directions of joint preservation
Pre-Course Hip Cadaver Lab:
Anterior Approach to the Hip, Hip Arthroscopy, and Extensile Exposure
Date: Thursday, August 22, 2013
Location: Anatomy Gifts Registry, Hanover, Maryland
Chair: Ronald E. Delanois, MD
Participants will gain first-hand experience in cadaveric dissections using various techniques for the treatment of arthritis and joint preservation of the hip. This lab will include the anterior approach, hip arthroscopy, and extensile exposure. Due to the low ratio of surgeons to specimens, registration is limited. LifeBridge Health designates this live educational activity for a maximum of 7.25 AMA PRA Category 1 CreditsTM.
- Improve visualization through the anterior approach
- Gain an understanding in the advances in treatment of femoroacetabular impingement through arthroscopy
- Practice total hip replacement using the technique that allows extensile
exposure of the hip and wide exposure of the proximal femoral diaphysis
Accreditation Statement for CME: LifeBridge Health is accredited by MedChi, the Maryland State Medical Society, to provide continuing medical education for physicians.
Designation Statement: LifeBridge Health designates this live educational activity for a maximum of 19.25 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Receiving CME Credit: You must sign in each day to receive CME credit hours. The sign-in sheets for the day will be available outside of the general session meeting room. If you do not sign in, you will not be able to claim the applicable credits.
Disclosures: In accordance with the ACCME requirements on disclosure information about relationships of presenters with commercial interests (if any) will be included in materials distributed at the time of the Course.
The following LifeBridge Health Continuing Medical Education Committee members and their spouses/partners have no financial interest or affiliation with the manufacturer or distributor of any medical products, devices or services: Madeline Bacon, Joseph Berkow, MD, John Cmar, MD, Lee Cook, Pat DeGrafenreid, Bruce Fellerman, Thomas Genuit, MD, Tina Gionet, Mark Katlic, MD, Dianah Lake, MD, Lorrie Liang, Diane Maloney-Krichmar, PhD, Andrew Mayrer, MD, Wendy Robinson, and Richard Rohrs, PA-C. However, David Gordon, MD, receives grant/research support, serves as a consultant/speaker, and is on the Advisory Board with Astellas, ACell, UroVal, Allergan, Pfizer, and American Medical System (AMS); Asha Thomas, MD, is the primary investigator for Bydureon/Lilly, co-investigator for Corlux/Corcept Therapeutics, and Samsca/Otsuka; and Joseph Wiley, MD, is on the speaker’s bureau for Pfizer and Sigma Tau.